Literature DB >> 30658078

IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease.

Fumie Ito1, Ryuta Kamekura2, Motohisa Yamamoto3, Kenichi Takano4, Hiromi Takaki5, Hayato Yabe5, Ippei Ikegami5, Katsunori Shigehara5, Tetsuo Himi4, Hiroki Takahashi3, Shingo Ichimiya5.   

Abstract

IgG4-related disease (IgG4-RD) is a chronic fibroinflammatory disease characterized by elevation of serum IgG4 level as well as infiltration of IgG4+ plasma cells in various affected organs. The etiology of IgG4-RD is still not fully understood. Since IgG4-RD is more prevalent in the elderly, aging in itself is considered to be an important risk factor of IgG4-RD. However, the relationship between the pathogenesis of IgG4-RD and immunosenescence remains unknown. To clarify age-related features underlying IgG4-RD, we focused on T follicular regulatory (Tfr) cells, which share forkhead box P3 with regulatory T cells, since the percentage of Tfr cells is known to depend on age. Studies of blood specimens from patients with IgG4-RD and from healthy volunteers demonstrated a marked elevation of circulating Tfr (cTfr) cells in patients with IgG4-RD. Moreover, the percentage of cTfr cells was significantly correlated with various clinical parameters including the level of serum IgG4 and the number of involved organs in IgG4-RD patients. The percentages of tonsillar and blood Tfr cells were increased with aging in healthy volunteers, whereas the suppressive effect of cTfr cells on B cell function in elderly subjects was impaired in comparison with that in young subjects due to a defect in the production of a regulatory cytokine, IL-10. Given that the number of IL-10-producing cTfr cells in IgG4-RD patients was markedly increased compared with that in healthy elderly subjects, these findings suggest that an abnormal aging process of Tfr cells may be related to the pathogenesis of IgG4-RD.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; IL-10; IgG4-related disease; Tfh cells; Tfr cells

Mesh:

Substances:

Year:  2019        PMID: 30658078     DOI: 10.1016/j.imlet.2019.01.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Regional disturbance of the distribution of T regulatory cells and T helper cells associated with irregular-shaped germinal centers in immunoglobulin G4-related sialadenitis.

Authors:  Satomi Kasashima; Atsuhiro Kawashima; Nozomu Kurose; Satoru Ozaki; Hiroko Ikeda; Ken-Ichi Harada
Journal:  Virchows Arch       Date:  2021-08-20       Impact factor: 4.064

Review 2.  [Immunoglobulin-G4-related disease].

Authors:  Jasper F Nies; Martin Krusche
Journal:  Z Rheumatol       Date:  2022-06-29       Impact factor: 1.530

Review 3.  Implications of Inflammatory States on Dysfunctional Immune Responses in Aging and Obesity.

Authors:  Alyssa L Thomas; Pablo C Alarcon; Senad Divanovic; Claire A Chougnet; David A Hildeman; Maria E Moreno-Fernandez
Journal:  Front Aging       Date:  2021-09-22

Review 4.  T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Autoimmune Dis       Date:  2022-06-20

Review 5.  Follicular regulatory T cells: a novel target for immunotherapy?

Authors:  Yao Huang; Zhe Chen; Hui Wang; Xin Ba; Pan Shen; Weiji Lin; Yu Wang; Kai Qin; Ying Huang; Shenghao Tu
Journal:  Clin Transl Immunology       Date:  2020-02-14

6.  IgG4-related Sclerosing Cholangitis Complicated with Cholangiocarcinoma and Detected by Forkhead Box P3 Immunohistochemical Staining.

Authors:  Tadashi Toyohara; Takahiro Nakazawa; Kais Zakharia; Shuya Shimizu; Katsuyuki Miyabe; Kenichi Harada; Kenji Notohara; Tomohiro Yamada; Katsumi Hayashi; Itaru Naitoh; Kazuki Hayashi; Hiromi Kataoka
Journal:  Intern Med       Date:  2020-10-21       Impact factor: 1.271

Review 7.  IgG4 as a Biomarker in Graves' Orbitopathy.

Authors:  Michał Olejarz; Ewelina Szczepanek-Parulska; Daniela Dadej; Nadia Sawicka-Gutaj; Remigiusz Domin; Marek Ruchała
Journal:  Mediators Inflamm       Date:  2021-06-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.